Suzhou Biomissile Pharmaceuticals Co., Ltd.
Suzhou Biomissile Pharmaceuticals Co., Ltd.
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase Ib/II Study of BM230 in Combination With PD-1 Inhibitor for HER2-related Advanced Solid Tumors | Solid Tumor | Not yet recruiting | Phase 1 / Phase 2 | 2026-10-09 | NCT07698587 | |
| Study of BM230 in Patients With Advanced Solid Tumors | Solid Tumor | Recruiting | Phase 1 | 2026-01-29 | NCT06644300 |